Harry Hendrikse

Harry Hendrikse is a Full Professor in the Department of Pharmacy at Erasmus Medical Center (Erasmus MC). His research focuses on pharmacokinetics, tyrosine kinase inhibitors, and advanced imaging techniques like positron emission tomography (PET) for drug development and cancer applications.

Research Interests

Hendrikse specializes in:

• Physiologically Based Pharmacokinetic (PBPK) modeling
• Drug distribution in target tissues
• Nuclear medicine imaging methodologies
• Quantitative analysis of radiotracers
• Clinical translation of kinase inhibitors

Recent Publications

His recent work includes developing computational PBPK models verified by PET imaging and optimizing quantitative methods for radiotracer analysis in pancreatobiliary cancers, reflecting his expertise in pharmacokinetics and precision oncology.